Pituitary Tumor Surveillance: Pathogenic Correlation
Launched by CEDARS-SINAI MEDICAL CENTER · Jan 11, 2008
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary: Pituitary Tumor Surveillance**
This clinical trial, titled "Pituitary Tumor Surveillance: Pathogenic Correlation," is focused on understanding how to better predict the chances of pituitary tumors coming back after treatment and to identify signs that the disease might still be active. This study is open to all adults aged 65 and older who have been diagnosed with a pituitary tumor, which is a growth that occurs in the pituitary gland located at the base of the brain. If you have a confirmed pituitary disease, you may be eligible to participate.
If you choose to join this study, you will be monitored to help researchers learn more about the behavior of pituitary tumors. The information gathered could lead to better care for future patients with similar conditions. The trial is currently recruiting participants, and it’s important to know that only individuals with a confirmed diagnosis of a pituitary tumor can take part. This study aims to help improve our understanding of these tumors and how to manage them effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with confirmed pituitary disease
- Exclusion Criteria:
- • patients who do not have confirmed pituitary disease
About Cedars Sinai Medical Center
Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Shlomo Melmed, MD
Principal Investigator
Cedars-Sinai Medical Center, Pituitary Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials